第一工業製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 化学 | 4461/E00885 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2019/01/04 | 日証協 | 104,827株 | -4.79% | 28,027株 | -44.94% | 216,222株 | -0.39% | 2,126株 | -92.29% |
2018/12/28 | 日証協 | 110,098株 | +6.24% | 50,901株 | -27.08% | 217,066株 | +3.06% | 27,574株 | -51.54% |
2018/12/21 | 日証協 | 103,629株 | +6.42% | 69,800株 | +10.53% | 210,623株 | +21.34% | 56,898株 | -18.49% |
2018/12/14 | 日証協 | 97,380株 | +24.16% | 63,150株 | +670.12% | 173,578株 | +36.15% | 69,805株 | +290.71% |
2018/12/07 | 日証協 | 78,431株 | +0.64% | 8,200株 | +57.57% | 127,491株 | +15.56% | 17,866株 | +18.32% |
2018/11/30 | 日証協 | 77,931株 | -8.78% | 5,204株 | -40.88% | 110,323株 | +3.28% | 15,100株 | +37.26% |
2018/11/22 | 日証協 | 85,431株 | -7.87% | 8,802株 | -82.33% | 106,823株 | +9.2% | 11,001株 | -52.78% |
2018/11/16 | 日証協 | 92,733株 | -7.22% | 49,802株 | -49.52% | 97,825株 | +1.77% | 23,299株 | -59.42% |
2018/11/09 | 日証協 | 99,950株 | +21.11% | 98,658株 | +104.59% | 96,125株 | -27.79% | 57,417株 | +70.88% |
2018/11/02 | 日証協 | 82,530株 | -13.82% | 48,222株 | +181.24% | 133,123株 | -2.07% | 33,600株 | +681.21% |
2018/10/26 | 日証協 | 95,760株 | -51.27% | 17,146株 | -19.21% | 135,943株 | -43.2% | 4,301株 | -69.32% |
2018/10/19 | 日証協 | 196,509株 | -0.15% | 21,222株 | -48.74% | 239,323株 | +1.75% | 14,021株 | -78.13% |
2018/10/12 | 日証協 | 196,801株 | +0.41% | 41,404株 | -84.21% | 235,204株 | -1.01% | 64,100株 | -32.17% |
2018/10/05 | 日証協 | 196,003株 | -70.57% | 262,207株 | -45.26% | 237,607株 | -72.86% | 94,502株 | +85.3% |
2018/09/28 | 日証協 | 666,099株 | +5.49% | 478,997株 | +196.87% | 875,599株 | -6.71% | 50,999株 | +86.41% |
2018/09/21 | 日証協 | 631,450株 | -2.29% | 161,350株 | +28.16% | 938,592株 | +3.77% | 27,359株 | -89.46% |
2018/09/14 | 日証協 | 646,250株 | +1.96% | 125,900株 | +14.45% | 904,526株 | -1.89% | 259,490株 | +69.34% |
2018/09/07 | 日証協 | 633,800株 | -18.84% | 110,000株 | +1733.33% | 921,968株 | -16.38% | 153,233株 | +141.05% |
2018/08/31 | 日証協 | 780,950株 | -0.63% | 6,000株 | -89.85% | 1,102,603株 | -0.45% | 63,568株 | -51.53% |
※株式分割は考慮していませんのでご注意ください。
Page Top